CLINICAL CASE OF CUTANEOUS MASTOCYTOSIS IN A CHILD
Keywords:
mastocytosis, clinical case, childrenAbstract
Mastocytosis is a group of rare diseases caused by the proliferation of mast cells in various organs and tissues. The article presents data on the prevalence, clinical manifestations and treatment of mastocytosis, as well as own clinical observations. The presented clinical case contains the features of the course of this disease in a child of the first year of life. The onset of the disease in early childhood (2.5 months) led to the complexity of the diagnosis of this process. The presented clinical observation reflects the relevance of the problem in medical practice. Timely diagnosis of this disease improves the prognosis and contributes to improving the quality of life of the child.
References
Belykh N.A., Amelina V.V. Znachenie deficita vitamina D v formirovanii bronxoobstruktivnogo sindroma u detej // Nauka molody`x (Eruditio Juvenium). 2019. T. 7, №2. S. 261-273.
Kasixina E.I., Kruglova L.S., Vashhenko M.O., Majorov R.Yu. Analiz faktorov riska, vliyayushhix na techenie mastocitoza kozhi u detej: odnomomentnoe issledovanie // Voprosy` sovremennoj pediatrii. 2020. T. 19, №6. S. 526-530.
Konovalova E.Yu., Lavrova A.E., Presnyakova M.V. Disfunkciya e`ndoteliya i narushenie trombocitarnogo zvena gemostaza pri razvitii fibroza pecheni u detej s autoimmunny`m gepatitom // Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova. 2018. T. 26., №4. S. 500-510.
Mastocitoz u detej / T.Yu. Lebedeva [i dr.] // Verxnevolzhskij medicinskij zhurnal. 2012. T. 10, №3. S. 26–32.
Mastocitoz (obzor literatury` i opisanie klinicheskix sluchaev) / A.L. Melikyan [i dr.] // Terapevticheskij arxiv. 2014. T.86, №12. S. 127-134.
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future/ P. Valent [et al] // Cancer Res. V. 77, N 6. P. 1261-1270.
Branford W.A. Edward Nettleship (1845–1913) and the description of urticaria pigmentosa // Int J Dermatol. 1994. V. 33, N 3. P. 214–6.
Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis // Immunol Allergy Clin North Am. 2014. V. 34, N 2. P. 283–95.
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology / K. Hartmann [et al] // J. Allergy Clin. Immunol. 2016. V. 137, N 1. P. 35–45.
Epidemiology of anaphylaxis: Findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group / P. Lieberman [et al] // Ann Allergy Asthma Immunol. 2006. V. 97, N 5. P. 596–602.
Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis / K. Brockow [et al] // Int J Mol Sci. 2021. V. 22, N 5. P. 2684.
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021 / M. Lange [et al] // Int J Mol Sci. 2021. V. 22, N 5. P. 2586.
New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the Annual Meeting of the European Competence Network on Mastocytosis (ECNM) 2019 / M. Arock [et al] // Leukemia and Lymphoma. 2020. V. 61, N 5. P 1075-10
